BOLT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 30.90%

Insider Buying (Last 12 Months): $2,525.00

Insider Selling (Last 12 Months): $0.00

Bolt Biotherapeutics Insider Trading History Chart

Bolt Biotherapeutics Share Price & Price History

^$5.09

▲ +0.18 (3.67%)

As of 02/24/2026 05:00 PM ET

Days: 30 | 90 | 365

Bolt Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/5/2025	Sarah Nemec	VP	Buy	125	$4.61	$576.25	1,415
12/5/2025	William P. Quinn	CEO	Buy	125	$4.61	$576.25	2,313
6/6/2025	Sarah Nemec	VP	Buy	125	$5.49	$686.25	943
6/6/2025	William P. Quinn	CEO	Buy	125	$5.49	$686.25	2,188
12/16/2024	Sarah Nemec	VP	Buy	125	$10.00	$1,250.00	831
6/6/2024	Sarah Nemec	VP	Buy	125	$12.80	$1,600.00	693
12/12/2023	William P. Quinn	CFO	Buy	375	$19.00	$7,125.00	1,813
12/6/2023	William P. Quinn	CFO	Buy	125	$15.60	$1,950.00	1,438
11/29/2023	Edgar Engleman	Director	Sell	1,290	$18.20	$23,478.00	13,322
11/20/2023	Edgar Engleman	Director	Sell	1,562	$18.40	$28,740.80	13,491
11/20/2023	Vivo Capital Viii, Llc	Major Shareholder	Sell	2,735	$18.40	$50,324.00	5,655
11/16/2023	Edgar Engleman	Director	Sell	428	$19.20	$8,217.60	13,737
11/16/2023	Vivo Capital Viii, Llc	Major Shareholder	Sell	750	$19.20	$14,400.00	7,178
6/6/2023	William P. Quinn	CFO	Buy	91	$23.60	$2,147.60	1,313

SEC Filings (Institutional Ownership Changes) for Bolt Biotherapeutics (NASDAQ:BOLT)

86.70% of Bolt Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Bolt Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/13/2026	Vivo Capital LLC	72,414	$0.40M	0.0%	-58.9%	3.772%
2/12/2026	Renaissance Technologies LLC	55,025	$0.30M	0.0%	+92.2%	2.866%
2/11/2026	T3 Companies LLC	38,000	$0.21M	0.3%	N/A	1.979%
2/6/2026	Nano Cap New Millennium Growth Fund L P	20,500	$0.11M	0.1%	N/A	1.068%
11/17/2025	Susquehanna International Group LLP	16,642	$89K	0.0%	N/A	0.867%
11/14/2025	Shay Capital LLC	15,958	$85K	0.0%	N/A	0.831%
11/14/2025	Squarepoint Ops LLC	14,836	$79K	0.0%	+19.8%	0.773%
8/15/2025	Sofinnova Investments Inc.	137,721	$0.80M	0.0%	-95.0%	7.173%
8/14/2025	Vivo Capital LLC	176,064	$0.99M	0.1%	-95.0%	9.170%
8/14/2025	Nan Fung Group Holdings Ltd	58,347	$0.34M	0.5%	-95.0%	3.039%
8/11/2025	Pfizer Inc	31,305	$0.18M	0.0%	-95.0%	1.630%
8/8/2025	Geode Capital Management LLC	18,533	$0.11M	0.0%	-95.1%	0.965%
7/31/2025	Board of Trustees of The Leland Stanford Junior University	35,978	$0.21M	0.0%	-95.0%	1.874%
2/17/2025	Velan Capital Investment Management LP	50,000	$27K	0.0%	N/A	0.131%
2/17/2025	Squarepoint Ops LLC	48,971	$26K	0.0%	N/A	0.128%
2/17/2025	Millennium Management LLC	47,025	$25K	0.0%	N/A	0.123%
2/17/2025	Citadel Advisors LLC	78,961	$42K	0.0%	N/A	0.206%
11/16/2024	Geode Capital Management LLC	352,426	$0.23M	0.0%	-5.0%	0.921%
11/13/2024	FMR LLC	115,386	$75K	0.0%	+33.2%	0.302%
8/9/2024	Renaissance Technologies LLC	276,739	$0.21M	0.0%	-46.5%	0.726%
8/5/2024	Acuitas Investments LLC	630,507	$0.47M	0.3%	+21.7%	1.654%
7/18/2024	Assenagon Asset Management S.A.	34,488	$26K	0.0%	N/A	0.090%
2/15/2024	Board of Trustees of The Leland Stanford Junior University	719,546	$0.81M	0.1%	-5.0%	1.895%
2/7/2024	Vivo Capital LLC	3,521,291	$3.94M	0.3%	-9.0%	9.274%
11/14/2023	Newtyn Management LLC	1,020,000	$1.06M	0.3%	+2.0%	2.688%
7/26/2023	Privium Fund Management B.V.	116,516	$0.15M	0.0%	N/A	0.308%
7/25/2023	Assenagon Asset Management S.A.	158,289	$0.20M	0.0%	-29.9%	0.419%
5/8/2023	Bailard Inc.	28,500	$40K	0.0%	N/A	0.075%
2/15/2023	Tang Capital Management LLC	400,000	$0.52M	0.1%	+100.0%	1.062%
2/14/2023	Susquehanna International Group LLP	20,307	$26K	0.0%	N/A	0.054%
2/8/2023	Russell Investments Group Ltd.	40,195	$52K	0.0%	-38.2%	0.107%
1/12/2023	Assenagon Asset Management S.A.	225,816	$0.29M	0.0%	-19.3%	0.600%
1/12/2023	Marquette Asset Management LLC	97,835	$0.13M	0.0%	+53.4%	0.260%
11/15/2022	Caas Capital Management LP	116,777	$0.17M	0.0%	N/A	0.310%
11/14/2022	RA Capital Management L.P.	533,432	$0.79M	0.0%	+18.5%	1.417%
11/14/2022	Ergoteles LLC	88,174	$0.13M	0.0%	-16.5%	0.234%
11/4/2022	Russell Investments Group Ltd.	64,995	$96K	0.0%	-32.4%	0.173%
11/1/2022	Privium Fund Management UK Ltd	116,516	$0.17M	0.2%	N/A	0.310%
10/18/2022	Bailard Inc.	46,383	$69K	0.0%	N/A	0.123%
7/29/2022	Russell Investments Group Ltd.	96,100	$0.20M	0.0%	N/A	0.256%
7/27/2022	Assenagon Asset Management S.A.	275,552	$0.56M	0.0%	N/A	0.735%
7/15/2022	Marquette Asset Management LLC	63,779	$0.13M	0.0%	N/A	0.170%
5/16/2022	Echo Street Capital Management LLC	123,804	$5.49M	0.0%	N/A	0.330%
5/11/2022	GSA Capital Partners LLP	54,038	$0.15M	0.0%	N/A	0.144%
5/9/2022	Qube Research & Technologies Ltd	19,611	$54K	0.0%	-57.0%	0.052%
2/19/2022	Woodline Partners LP	403,357	$1.98M	0.0%	+2.3%	1.082%
2/14/2022	Suvretta Capital Management LLC	2,230,250	$10.93M	0.2%	+68.3%	5.982%
2/14/2022	Eventide Asset Management LLC	1,449,494	$7.10M	0.1%	+171.4%	3.888%
2/11/2022	Ensign Peak Advisors Inc	18,500	$91K	0.0%	-36.0%	0.050%
2/10/2022	Qube Research & Technologies Ltd	45,640	$0.22M	0.0%	+204.2%	0.122%
2/8/2022	ProShare Advisors LLC	10,249	$50K	0.0%	N/A	0.027%
2/8/2022	Northern Trust Corp	194,893	$0.96M	0.0%	+4.3%	0.523%
2/7/2022	SG Americas Securities LLC	10,490	$51K	0.0%	-25.5%	0.028%
2/2/2022	New York State Common Retirement Fund	10,388	$51K	0.0%	+129.5%	0.028%
2/1/2022	Qube Research & Technologies Ltd	45,640	$0.22M	0.0%	+204.2%	0.122%
11/16/2021	Metropolitan Life Insurance Co NY	7,197	$91K	0.0%	N/A	0.019%
11/15/2021	Point72 Hong Kong Ltd	2,094	$26K	0.0%	N/A	0.006%
11/15/2021	California State Teachers Retirement System	23,230	$0.29M	0.0%	+45.6%	0.062%
11/12/2021	Renaissance Technologies LLC	79,300	$1M	0.0%	+31.1%	0.213%
11/12/2021	The Manufacturers Life Insurance Company	11,017	$0.14M	0.0%	N/A	0.030%
11/12/2021	Geode Capital Management LLC	345,115	$4.37M	0.0%	+64.2%	0.928%
11/10/2021	Citigroup Inc.	2,842	$36K	0.0%	+262.0%	0.008%

Data available starting January 2016

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Today's Range

Now: $5.09

$4.92

$5.26

50 Day Range

MA: $5.66

$4.67

$7.09

52 Week Range

Now: $5.09

$4.27

$9.78

Volume

12,493 shs

Average Volume

33,702 shs

Market Capitalization

$9.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Bolt Biotherapeutics?: Bolt Biotherapeutics' top insider investors include:
William P Quinn (CEO)
Sarah Nemec (VP)
Learn More about top insider investors at Bolt Biotherapeutics.
Who are the major institutional investors of Bolt Biotherapeutics?: Bolt Biotherapeutics' top institutional shareholders include:
Vivo Capital LLC — 3.77%
Renaissance Technologies LLC — 2.87%
T3 Companies LLC — 1.98%
Nano Cap New Millennium Growth Fund L P — 1.07%
Learn More about top institutional investors of Bolt Biotherapeutics stock.
Which institutional investors are selling Bolt Biotherapeutics stock?: In the last quarter, BOLT stock was sold by these institutional investors:
Vivo Capital LLC
Which institutional investors are buying Bolt Biotherapeutics stock?: During the previous quarter, BOLT stock was purchased by institutional investors including:
T3 Companies LLC
Renaissance Technologies LLC
Nano Cap New Millennium Growth Fund L P
In the last year, these company insiders have bought Bolt Biotherapeutics stock:
William P Quinn (CEO)
Sarah Nemec (VP)
Learn More investors buying Bolt Biotherapeutics stock.